Cargando…
Genetically Engineered Live-Attenuated Middle East Respiratory Syndrome Coronavirus Viruses Confer Full Protection against Lethal Infection
There are no approved vaccines against the life-threatening Middle East respiratory syndrome coronavirus (MERS-CoV). Attenuated vaccines have proven their potential to induce strong and long-lasting immune responses. We have previously described that severe acute respiratory syndrome coronavirus (SA...
Autores principales: | Gutiérrez-Álvarez, Javier, Honrubia, José M., Fernández-Delgado, Raúl, Wang, Li, Castaño-Rodríguez, Carlos, Zúñiga, Sonia, Sola, Isabel, Enjuanes, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092200/ https://www.ncbi.nlm.nih.gov/pubmed/33653888 http://dx.doi.org/10.1128/mBio.00103-21 |
Ejemplares similares
-
Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice
por: Gutiérrez-Álvarez, J., et al.
Publicado: (2021) -
Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine Candidate
por: Almazán, Fernando, et al.
Publicado: (2013) -
Molecular Basis of Coronavirus Virulence and Vaccine Development
por: Enjuanes, L., et al.
Publicado: (2016) -
Biochemical Aspects of Coronavirus Replication
por: Enjuanes, Luis, et al.
Publicado: (2006) -
MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity
por: Wang, Li, et al.
Publicado: (2021)